Natural Biocon (India) Ltd.

As of June 30, 2026, Natural Biocon (India) Ltd. carries a market capitalization of 96.69M, placing it among publicly traded companies globally. Its enterprise value stands at 96.69M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Natural Biocon (India) Ltd. has 25.78M shares outstanding.

These figures are as of June 30, 2026.

These figures are as of June 30, 2026. The EV/Sales ratio of 11.01 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 96.69M versus a market cap of 96.69M, with the gap driven by net debt and cash on the balance sheet.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 2.93M in revenue per employee across its workforce of 3.00, a quick read on workforce productivity versus industry peers.

As of the close on October 22, 2026, Natural Biocon (India) Ltd.'s stock has declined approximately 68.17% over the past 52 weeks. The 50-day moving average sits at 3.13, while the 200-day moving average is 3.72.

Over the twelve months ended June 30, 2026, Natural Biocon (India) Ltd. generated 8.79M in revenue and converted that into -1.91M in net income, yielding earnings per share of -0.08. EBITDA reached -1.89M, while operating income came in at -1.93M.

Over the twelve months ended June 30, 2026, Natural Biocon (India) Ltd. posted a gross margin of 19.72, reflecting its pricing power and cost economics. The operating margin of -21.92 and net profit margin of -21.79 provide insight into operational efficiency.